Clinical Infectious Diseases · 2023 · 10 citations · 23 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationVaccine ImmunologyVaccinologyAdverse Events Following ImmunizationImmunization PracticeVaccinationVaccine EfficacyVaccine SafetyVaccine-preventable DiseasesAnimal ImmunizationRabies Exposure ProphylaxisRabies Pre-exposure ProphylaxisRabies VaccinesRabies VirusSide-by-side ComparisonSide-to-side ComparisonT Cell Response Induction
All World Health Organization (WHO) pre-qualified rabies vaccines for humans are inactivated tissue culture rabies virus formulations produced for intramuscular (IM) administration. Due to costs and vaccine shortage, dose-saving intradermal (ID) administration of rabies post-exposure prophylaxis (PEP) is encouraged by WHO. This study compared the immunogenicity of the ID 2-site, 3-visit Institut Pasteur Cambodge (IPC) PEP regimen to the IM 1-site, 4-visit 4-dose Essen regimen using Verorab vaccine (Sanofi). The development of neutralizing antibodies (nAbs) and T cell response was assessed in 210 patients with a category II or III animal exposure in a rabies-endemic country. At day 28, all participants developed nAbs (≥0.5 IU/mL), irrespective of PEP scheme, age, or administration of rabies immunoglobulin. T cell response and nAb titers were similar for both PEP schemes. This study demonstrated that the 1-week ID IPC regimen is as effective as the 2-week IM 4-dose Essen regimen in inducing an anti-rabies immune response under real-life PEP.
23
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan, José Mateus, Yu Kato et al. · Science · 2021 · 3K citations · Full text
Estimating the Global Burden of Endemic Canine Rabies
Katie Hampson, Laurent Coudeville, Tiziana Lembo et al. · PLoS neglected tropical diseases · 2015 · 1.8K citations · Full text